Also, the use of a MEK1/2 inhibitor significantly reduced Slc7a5 transcription in mouse thyroid tumors model [59] emphasizing the role of the RAS-MEK-ERK pathway in LAT1 regulation. This evidence concerns the gene SLC7A5 and thyroid tumor.